Abstract
Human maltase glucoamylase (MGAM) is a potent molecular target for controlling post prandial glucose surplus in type 2 diabetes. Binding of small molecules from Syzygium sp. with α-glucosidase inhibitory potential in MGAM has been investigated in silico. Our results suggest that myricetin was the most potent inhibitor with high binding affinity for both N- and C-terminals of MGAM. Molecular dynamics revealed that myricetin interacts in its stretched conformation through water-mediated interactions with C-terminal of MGAM and by normal hydrogen bonding with the N-terminal. W1369 of the extended 21 amino acid residue helical loop of C-terminal plays a major role in myricetin binding. Owing to its additional sugar sites, overall binding of small molecules favours C-terminal MGAM.
Similar content being viewed by others
References
Åqvist, J., & Hansson, T. (1996). The Journal of Physical Chemistry, 100, 9512–9521.
Asano, N. (2003). Glycobiology, 13, 93R–104R.
Beecher, G. R. (2003). Journal of Nutrition, 133, 3248S–3254S.
Benalla, W., Bellahcen, S., & Bnouham, M. (2010). Current Diabetes Review, 6, 247–254.
Ceriello, A. (2005). Diabetes, 54, 1–7.
Cortés Cabrera, A., & Rueda Pérez, C. (2010) Anales de la Real Academia Nacional de Farmacia, pp. 3.
Goodsell, D. S., Morris, G. M., & Olson, A. J. (1996). Journal of Molecular Recognition, 9, 1–5.
Grover, J. K., Yadav, S., & Vats, V. (2002). Journal of Ethnopharmacology, 81, 81–100.
Gunther, S., Wehrspaun, A., & Heymann, H. (1996). Archives of Biochemistry & Biophysics, 327, 295–302.
Helmstadter, A. (2008). Die Pharmazie-An International Journal of Pharmaceutical Sciences, 63, 91–101.
Hornak, V., Abel, R., Okur, A., Strockbine, B., Roitberg, A., & Simmerling, C. (2006). Proteins, 65, 712–725.
Lattig, J., Bohl, M., Fischer, P., Tischer, S., Tietbohl, C., Menschikowski, M., et al. (2007). Journal of Computer Aided Molecular Design, 21, 473–483.
Manaharan, T., Appleton, D., Cheng, H. M., & Palanisamy, U. D. (2012). Food Chemistry, 132, 1802–1807.
Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., et al. (2009). Journal of Computational Chemistry, 30, 2785–2791.
Nichols, B. L., Avery, S., Sen, P., Swallow, D. M., Hahn, D., & Sterchi, E. (2003). Proceedings of the National Academy of Sciences of the United States of America, 100, 1432–1437.
Nichols, B. L., Eldering, J., Avery, S., Hahn, D., Quaroni, A., & Sterchi, E. (1998). Journal of Biological Chemistry, 273, 3076–3081.
Nichols, B. L., Quezada-Calvillo, R., Robayo-Torres, C. C., Ao, Z., Hamaker, B. R., Butte, N. F., et al. (2009). Journal of Nutrition, 139, 684–690.
Oliveira, A. C., Endringer, D. C., Amorim, L. A., das Gracas, L. B. M., & Coelho, M. M. (2005). Journal of Ethnopharmacology, 102, 465–469.
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., et al. (2004). Journal of Computational Chemistry, 25, 1605–1612.
Quezada-Calvillo, R., Sim, L., Ao, Z., Hamaker, B. R., Quaroni, A., Brayer, G. D., et al. (2008). Journal of Nutrition, 138, 685–692.
Ren, L., Cao, X., Geng, P., Bai, F., & Bai, G. (2011). Carbohydrate Research, 346, 2688–2692.
Ren, L., Qin, X., Cao, X., Wang, L., Bai, F., Bai, G., et al. (2011). Protein & Cell, 2, 827–836.
Samadder, A., Chakraborty, D., De, A., Bhattacharyya, S. S., Bhadra, K., & Khuda-Bukhsh, A. R. (2011). European Journal of Pharmaceutical Sciences, 44, 207–217.
Sharma, S. B., Nasir, A., Prabhu, K. M., & Murthy, P. S. (2006). Journal of Ethnopharmacology, 104, 367–373.
Sharma, S. B., Nasir, A., Prabhu, K. M., Murthy, P. S., & Dev, G. (2003). Journal of Ethnopharmacology, 85, 201–206.
Shinde, J., Taldone, T., Barletta, M., Kunaparaju, N., Hu, B., Kumar, S., et al. (2008). Carbohydrate Research, 343, 1278–1281.
Sim, L., Quezada-Calvillo, R., Sterchi, E. E., Nichols, B. L., & Rose, D. R. (2008). Journal of Molecular Biology, 375, 782–792.
Sousa da Silva, A. W., & Vranken, W. F. (2012). BMC Research Notes, 5, 367.
Srivastava, S., & Chandra, D. (2013). Journal of the Science of Food and Agriculture, 93(9), 2084–2093.
Teixeira, C. C., Pinto, L. P., Kessler, F. H., Knijnik, L., Pinto, C. P., Gastaldo, G. J., et al. (1997). Journal of Ethnopharmacology, 56, 209–213.
Teixeira, C. C., Weinert, L. S., Barbosa, D. C., Ricken, C., Esteves, J. F., & Fuchs, F. D. (2004). Diabetes Care, 27, 3019–3020.
Van de Laar, F.A., Lucassen, P.L., Akkermans, R.P., Van de Lisdonk, E.H., Rutten, G.E., & Van Weel, C. (2005). Cochrane Database of Systematic Reviews, CD003639.
Wang, J., Wang, W., Kollman, P. A., & Case, D. A. (2006). Journal of Molecular Graphics and Modelling, 25, 247–260.
Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A., & Case, D. A. (2004). Journal of Computational Chemistry, 25, 1157–1174.
Yoshikawa, M., Morikawa, T., Matsuda, H., Tanabe, G., & Muraoka, O. (2002). Bioorganic & Medicinal Chemistry, 10, 1547–1554.
Yoshikawa, M., Murakami, T., Yashiro, K., & Matsuda, H. (1998). Chemical & pharmaceutical bulletin, 46, 1339.
Acknowledgments
We thank the School of Biosciences and Technology, VIT University for providing funds and infrastructure for this work. We gratefully acknowledge the CDAC supercomputing grid facility, BRAF for providing cluster computer network for running the simulations.
Author information
Authors and Affiliations
Corresponding author
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
ESM 1
(DOCX 24 kb)
Rights and permissions
About this article
Cite this article
Roy, D., Kumar, V., Acharya, K.K. et al. Probing the Binding of Syzygium-Derived α-Glucosidase Inhibitors with N- and C-Terminal Human Maltase Glucoamylase by Docking and Molecular Dynamics Simulation. Appl Biochem Biotechnol 172, 102–114 (2014). https://doi.org/10.1007/s12010-013-0497-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-013-0497-3